153 related articles for article (PubMed ID: 11913623)
1. Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center.
Williams ML; Morris MT; Ahmad U; Yousseff M; Li W; Ertel N;
Ethn Dis; 2002; 12(1):S1-58-62. PubMed ID: 11913623
[TBL] [Abstract][Full Text] [Related]
2. Use of smoking cessation interventions and aspirin for secondary prevention: are there racial disparities?
Ambriz EH; Woodard LD; Kressin NR; Petersen LA
Am J Med Qual; 2004; 19(4):166-71. PubMed ID: 15368781
[TBL] [Abstract][Full Text] [Related]
3. Impact of adding ezetimibe to statin to achieve low-density lipoprotein cholesterol goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial).
Maron DJ; Hartigan PM; Neff DR; Weintraub WS; Boden WE;
Am J Cardiol; 2013 Jun; 111(11):1557-62. PubMed ID: 23538020
[TBL] [Abstract][Full Text] [Related]
4. Optimizing statin treatment for primary prevention of coronary artery disease.
Hayward RA; Krumholz HM; Zulman DM; Timbie JW; Vijan S
Ann Intern Med; 2010 Jan; 152(2):69-77. PubMed ID: 20083825
[TBL] [Abstract][Full Text] [Related]
5. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
[TBL] [Abstract][Full Text] [Related]
6. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
[TBL] [Abstract][Full Text] [Related]
7. Outcome monitoring of fluvastatin in a Department of Veterans Affairs lipid clinic.
Kellick KA; Burns K; McAndrew E; Haberl E; Hook N; Ellis A
Am J Cardiol; 1995 Jul; 76(2):62A-64A. PubMed ID: 7604801
[TBL] [Abstract][Full Text] [Related]
8. [Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].
Simonyi G
Orv Hetil; 2014 Apr; 155(17):669-75. PubMed ID: 24755449
[TBL] [Abstract][Full Text] [Related]
9. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
[TBL] [Abstract][Full Text] [Related]
10. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
Nanna MG; Navar AM; Zakroysky P; Xiang Q; Goldberg AC; Robinson J; Roger VL; Virani SS; Wilson PWF; Elassal J; Lee LV; Wang TY; Peterson ED
JAMA Cardiol; 2018 Aug; 3(8):739-748. PubMed ID: 29898219
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
12. Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.
Plosker GL; Dunn CI; Figgitt DP
Drugs; 2000 Nov; 60(5):1179-206. PubMed ID: 11129127
[TBL] [Abstract][Full Text] [Related]
13. Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines.
Maviglia SM; Teich JM; Fiskio J; Bates DW
J Gen Intern Med; 2001 Aug; 16(8):531-7. PubMed ID: 11556929
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy.
Yood MU; McCarthy BD; Kempf J; Kucera GP; Wells K; Oliveria S; Stang P
Am Heart J; 2006 Oct; 152(4):777-84. PubMed ID: 16996858
[TBL] [Abstract][Full Text] [Related]
15. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study.
Ballantyne CM; Hoogeveen RC; Raya JL; Cain VA; Palmer MK; Karlson BW;
Atherosclerosis; 2014 Jan; 232(1):86-93. PubMed ID: 24401221
[TBL] [Abstract][Full Text] [Related]
17. The use of percutaneous coronary intervention in black and white veterans with acute myocardial infarction.
Maynard C; Sun H; Lowy E; Sales AE; Fihn SD
BMC Health Serv Res; 2006 Aug; 6():107. PubMed ID: 16923183
[TBL] [Abstract][Full Text] [Related]
18. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
[TBL] [Abstract][Full Text] [Related]
19. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
[TBL] [Abstract][Full Text] [Related]
20. The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
Koren MJ; Smith DG; Hunninghake DB; Davidson MH; McKenney JM; Weiss SR; Schrott HG; Henley RW; Tresh P; McLain RW; Bakker-Arkema RG; Black DM
Pharmacoeconomics; 1998 Jul; 14(1):59-70. PubMed ID: 10182195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
